Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer

Breast Cancer Research and Treatment
G HosteP Neven

Abstract

We aimed to investigate the role of palbociclib, a first-in-class cyclin-dependent kinase 4 and 6 inhibitor, in postmenopausal women with highly pretreated endocrine therapy-resistant metastatic breast cancer (MBC). Between 28 September 2015 and 14 March 2017, a compassionate use program was established in the University Hospitals Leuven in which 82 postmenopausal women with estrogen receptor-positive, HER2-negative MBC were included after at least four lines of systemic treatment. The efficacy and safety analysis was performed in 82 patients who had received at least one dose of palbociclib and who had at least 6-month follow-up at the data cut-off point. The primary objective was the evaluation of efficacy of the combination of palbociclib and endocrine therapy with clinical benefit as primary endpoint, defined as the absence of progressive disease and being on treatment for at least 6 months. Secondary objectives were the evaluation of toxicity and the identification of potential predictors for clinical benefit. The median age of the patients was 67.1 years (range 34.8-85.9) at the time of inclusion. The average duration of treatment was 5.6 months (range 1-19), with a median progression-free survival of 3.17 (95% CI 2.76-4....Continue Reading

References

Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Dec 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angela DeMichelePeter O'Dwyer
Feb 13, 2015·International Journal of Clinical Oncology·Hirotaka Iwase, Yutaka Yamamoto
Jun 2, 2015·The New England Journal of Medicine·Nicholas C TurnerUNKNOWN PALOMA3 Study Group
Sep 2, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Julia A BeaverPatricia Cortazar
Dec 4, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wenyue HuAida I Sacaan
Jun 9, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charlotte FribbensNicholas C Turner
Nov 3, 2016·Nature Reviews. Clinical Oncology·Diana Romero
Dec 14, 2016·The New England Journal of Medicine·Richard S FinnDennis J Slamon
Feb 16, 2017·Current Treatment Options in Oncology·Ami N Shah, Massimo Cristofanilli
Apr 26, 2017·Journal of Hematology & Oncology·Hanxiao XuKongming Wu
Apr 28, 2017·The Breast : Official Journal of the European Society of Mastology·Christian MaurerMichail Ignatiadis
May 11, 2017·Targeted Oncology·Esther S Kim, Lesley J Scott
May 23, 2017·Therapeutic Advances in Medical Oncology·Paule AugereauMario Campone
May 24, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maura N DicklerJosé Baselga
Jun 6, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George W SledgeAntonio Llombart-Cussac
Jun 29, 2017·Current Medical Research and Opinion·Burak BilginBülent Yalçın

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.